Tazicef
® (
ceftazidime) is an injectable antibiotic approved for the treatment of a variety of different types of infections. It is given either intravenously (by IV) or intramuscularly (injected into a muscle). The medication is most often used in hospitals or other similar settings.
Who Makes This Medication?
Tazicef is made by Sandoz GmbH for Hospira Worldwide, Inc.
Tazicef belongs to a class of antibiotics known as cephalosporins. Cephalosporins are part of a larger group of medications known as beta-lactam antibiotics (named after the ring-like "lactam" structure of these drugs). Tazicef works by stopping bacteria from making cell walls, which eventually causes the bacteria to die. Cephalosporins are related to penicillins.
When and How to Take Tazicef
General considerations to keep in mind when using Tazicef include the following:
- This medication is given by IV or by intramuscular injection, usually once every 8 or 12 hours (perhaps less often if you have kidney disease).
- For serious infections, it is usually best to give this drug by IV, not by intramuscular injection.
- When injected intramuscularly, a large muscle (such as the gluteus maximus) is used.
- Tazicef is often given for a few days after the infection has cleared up. For serious infections, an even longer treatment may be recommended.
HealthSavvy Sign In
|
